|
Research Division
Consultants
for Clinical Research (CCR) is a multi-specialty research facility
that has been involved in clinical research evaluating new investigational
and existing medications, as well as medical devices for over 18
years. We believe that providing the patient with alternatives for
therapy, quality care, and education are important aspects of patient
care.
Visit Consultants for Clinical
Research on the web at
www.ccrstudy.com
What
is clinical research?
When
a Pharmaceutical Company has a new investigational medication or
one that is already approved but to be given for a new condition
or at a new dose, a study is designed to collect information to
prove that the medication is safe and effective. Your doctor may
ask you if you are interested in participating in a study. The reasons
for suggesting this may be many. Sometimes conventional treatments
may not be appropriate for your condition or your doctor feels that
your participation in the study may provide you more thorough follow-up
as required by the study. Whatever the reasons, you should ask why
he/she has asked you to consider being in a study. There may also
be other reasons why you will be asked to be in a study.
How do I find
out more about the study?
Your
doctor will provide you with information about the study and introduce
you to a study coordinator (this individual is responsible for conducting
the study under your doctor's supervision). Together they will go
into detail about your illness and the various treatment options.
The study will be discussed in more detail and a copy of the informed
consent will be reviewed with you. A copy of this consent will be
given to you to take home and read. You should also understand that
your participation is voluntary and if you should decide not to
participate in a study, you will not be penalized in any way nor
will your standard of care be affected.
What
types of studies are performed?
We
often have studies looking at the following conditions:
-
Ulcerative
Colitis
-
Irritable
Bowel Syndrome (IBS)
-
Crohn's
Disease
-
Hepatitis
-
Peptic
Ulcer Disease
-
Erosive
Esophagitis
-
Reflux
Esophagitis (GERD)
-
Dyspepsia
-
Gastroparesis
-
Helicobacter
Pylori treatments
-
Pain
Management
-
Osteoarthritis
-
Diabetes
-
Rheumatoid
Arthritis
-
Bronchitis
-
Pneumonia
-
Ear
Infection
-
Hemorrhoids
If
you would like more information on any of these studies or future
studies, contact
us at (513) 872-4549 or e-mail us at info@ccrstudy.com
or visit our website,
www.ccrstudy.com
What
happens next?
Once
you have made your decision to participate in the study a coordinator
will be assigned to your care and will work directly with your doctor
(we call this the research team). It will be the coordinators responsibility
to schedule and be present at all study-related appointments and
procedures. It is very important that you answer all questions truthfully
and trust this person. The research team will be asking information
about your past and present medical history, medications, social
history and other information required by the study. It is important
that you keep them updated about visits to other physicians or changes
in your medications while in the study. The team will also be available
to answer any questions or talk with you about any problems day
or night as needed.
What
is Informed Consent?
This
is a form that you will be asked to sign should you choose to participate
in the study. It is a process by which you voluntarily agree to
participate, after all aspects of the study are explained and all
your questions have been answered to your satisfaction.
What
types of studies are there and what is a placebo?
There
are several types of studies that the FDA (Food and Drug Administration)
and the Pharmaceutical Company (the organization that is sponsoring
the study) have agreed to perform. Some are "Blinded/Masking" and
others are "Comparator". The informed consent title will tell you
which type of study you are being asked to participate in.
-
Blinded/Masking:
Single-blind usually refers to you not knowing which treatment
you will receive. Double-blind usually refers to you, your doctor,
and perhaps others not knowing which treatment you will receive.
-
Comparator:
This can be an investigational or marketed product, or placebo.
Investigational is the medication or placebo being tested or used
in the study. Placebo is an inactive substance that looks identical
to the medication being studied and is assigned by chance or like
a flip of the coin.
Once
you have completed the study?
All
information gathered during the study will be provided to your family
doctor and other doctors upon your request. If additional treatment
for your medical condition is needed, you will be advised on whom
to see for follow-up. The research team will no longer be needed
to coordinate your care but we will still be available for questions
or concerns if the need should arise.

Fact
Sheet
Professional,
Knowledgeable, Experienced Research Staff
Our
staff consists of eight full-time research coordinators, three of
which are certified in clinical research. We have Physicians who
are board-certified or board-eligible in their respective fields
and Physician Assistants dedicated to research activities. Our staff
is dedicated to quality patient care and education.
We
have successfully completed over 300 clinical trials with numerous
pharmaceutical companies and contract research organizations (CRO)
in the following areas:
-
Gastroenterology
-
Hepatology
-
Rheumatology
-
Orthopedics
-
Endocrine
-
Family
Practice
-
Pulmonary
-
Cardiology
-
Gynecology
Our
research team is experienced with all aspects of clinical investigations
and has a thorough knowledge of FDA regulations and ICH guidelines.
We
have an excellent Internal, Sponsor, and FDA audit record.
Facilities
-
Comfortable,
spacious, equipped office space with locked drug storage area
all maintained in accordance with FDA guidelines.
-
Outpatient
Ambulatory Surgical Center onsite with state of the art equipment.
-
All
study records are easily accessible and maintained on site.
-
Computerized
database of over 125,000 patients.
-
Physicians
affiliated with all thirteen (13) area hospitals.
Timely Enrollment Completion and Data
Submission
-
Regulatory
document completion within two weeks.
-
Ability
to utilize central or local Institutional Review Boards.
-
Rapid
patient recruitment.
Highest
Quality Data
-
Study
specific source documentation insures accurate and thorough collection
and verification of information.
-
Strict
protocol adherence.
-
Prompt
data entry and case report form corrections
-
Quality
Assurance audits on all data.

For more information about current
and upcoming studies, locations, general information about clinical
research or
Consultants for Clinical Research,
visit www.ccrstudy.com
|